Twist Bioscience Corporation Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period
Twist Bioscience Corporation (TWST) reported Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period of 104.00 thousand shares for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod · last filed 2026-08-03
- Twist Bioscience Corporation share-based compensation arrangement by share-based payment award, shares issued in period for the quarter ending 2026-06-30 was 0.00 shares.
- Twist Bioscience Corporation share-based compensation arrangement by share-based payment award, shares issued in period for the quarter ending 2026-03-31 was 104.00K shares, a 60.00% increase year-over-year.
- Twist Bioscience Corporation share-based compensation arrangement by share-based payment award, shares issued in period for the quarter ending 2025-12-31 was 0.00 shares.
- Twist Bioscience Corporation share-based compensation arrangement by share-based payment award, shares issued in period for the quarter ending 2025-06-30 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 9 month |
|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-03 | 104.00K shares derived: sum of 2 quarters · filed 2026-08-03 | 104.00K shares 10-Q · filed 2026-08-03 |
| 2026-03-31 | 104.00K shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-05-04 | 104.00K shares 10-Q · filed 2026-05-04 | |
| 2025-12-31 | 0.00 shares 10-Q/A · filed 2026-02-26 | ||
| 2025-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-04 | 65.00K shares derived: sum of 2 quarters · filed 2025-08-04 | 65.00K shares 10-Q · filed 2025-08-04 |
| 2025-03-31 | 65.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-05 | 65.00K shares 10-Q · filed 2025-05-05 | |
| 2024-12-31 | 0.00 shares 10-Q · filed 2025-02-03 | ||
| 2024-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-02 | 124.00K shares derived: sum of 2 quarters · filed 2024-08-02 | 124.00K shares 10-Q · filed 2024-08-02 |
| 2024-03-31 | 124.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-02 | 124.00K shares 10-Q · filed 2024-05-02 | |
| 2023-12-31 | 0.00 shares 10-Q · filed 2024-02-02 | ||
| 2023-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-07 | 132.00K shares derived: sum of 2 quarters · filed 2023-08-07 | 132.00K shares 10-Q · filed 2023-08-07 |
| 2023-03-31 | 132.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-08 | 132.00K shares 10-Q · filed 2023-05-08 | |
| 2022-12-31 | 0.00 shares 10-Q · filed 2023-02-07 | ||
| 2022-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-08 | 50.00K shares 10-Q · filed 2022-08-08 | |
| 2022-03-31 | 50.00K shares 10-Q · filed 2022-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |